Ocular implant project receives €1.4 million

Article

BIOSURF, a research project to develop ocular implants, has been awarded a Ocular implant project receives €1.4 million grant by German Minister Dr Schavan.

BIOSURF, a research project to develop ocular implants, has been awarded a Ocular implant project receives €1.4 million grant by German Minister Dr Schavan.

The grant has been issued to alamedics, Offenhäuser & Berger, the Max-Planck Institute for Intelligent Systems and the Laser Institute in order to develop a new generation of ocular implants for glaucoma.

Dr Christian Lingenfelder, general manager of alamedics and coordinator of the project group, explained, "The implants will allow for better control of intraocular pressure. The newly designed surfaces of artificial intraocular lenses, a combination of innovative materials and nanostructures, will allow for significantly better night vision. Additionally, the interaction of implant and body after implantation will be much better controlled."

Dr Schavan commented, "The BIOSURF research group over the next three years wants to explore new biomaterials and to create nanostructures, which allow controlled interaction of the human body with the implants. To better control the function and durability of the implant, the biomimetic structures researched in this project, will support regeneration of the interface between implant and body."

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.